New Zealand markets close in 6 hours

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
49.96+0.17 (+0.34%)
At close: 4:00PM EDT
50.06 +0.10 (+0.20%)
After hours: 05:35PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5124.19B
Enterprise value 3138.05B
Trailing P/E 18.62
Forward P/E 112.27
PEG ratio (5-yr expected) 13.09
Price/sales (ttm)2.87
Price/book (mrq)1.70
Enterprise value/revenue 33.68
Enterprise value/EBITDA 712.40

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 35.04%
S&P500 52-week change 334.68%
52-week high 354.26
52-week low 344.76
50-day moving average 348.60
200-day moving average 351.22

Share statistics

Avg vol (3-month) 32.02M
Avg vol (10-day) 31.79M
Shares outstanding 52.51B
Implied shares outstanding 6N/A
Float 82.22B
% held by insiders 10.00%
% held by institutions 18.30%
Shares short (29 Sep 2021) 47.07M
Short ratio (29 Sep 2021) 42.9
Short % of float (29 Sep 2021) 4N/A
Short % of shares outstanding (29 Sep 2021) 40.28%
Shares short (prior month 30 Aug 2021) 45.25M

Dividends & splits

Forward annual dividend rate 41.93
Forward annual dividend yield 43.87%
Trailing annual dividend rate 33.20
Trailing annual dividend yield 36.43%
5-year average dividend yield 43.83
Payout ratio 469.13%
Dividend date 325 May 2021
Ex-dividend date 402 May 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 15.47%
Operating margin (ttm)21.51%

Management effectiveness

Return on assets (ttm)4.43%
Return on equity (ttm)9.22%

Income statement

Revenue (ttm)37.55B
Revenue per share (ttm)14.98
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)25.27B
EBITDA 10.75B
Net income avi to common (ttm)5.81B
Diluted EPS (ttm)2.68
Quarterly earnings growth (yoy)-84.10%

Balance sheet

Total cash (mrq)9.72B
Total cash per share (mrq)3.88
Total debt (mrq)21.65B
Total debt/equity (mrq)34.17
Current ratio (mrq)1.55
Book value per share (mrq)25.24

Cash flow statement

Operating cash flow (ttm)8.28B
Levered free cash flow (ttm)6.24B